GW Pharmaceuticals Plc – American Depositary Shares Given a $65.00 Price Target by Lazard Capital Markets Analysts (GWPH)
Research analysts at Lazard Capital Markets set a $65.00 price objective on shares of GW Pharmaceuticals Plc – American Depositary Shares (NASDAQ:GWPH) stock in a report released on Monday, AR Network reports. Lazard Capital Markets’ price target would indicate a potential upside of 163.16% from the company’s current price.
Separately, analysts at Cowen and Company raised their price target on shares of GW Pharmaceuticals Plc – American Depositary Shares from $27.95 to $28.33 in a research note to investors on Tuesday, August 6th. Three equities research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and a consensus price target of $29.07.
Shares of GW Pharmaceuticals Plc – American Depositary Shares (NASDAQ:GWPH) opened at 24.70 on Monday. GW Pharmaceuticals Plc – American Depositary Shares has a 1-year low of $8.46 and a 1-year high of $24.70. The stock has a 50-day moving average of $14.22 and a 200-day moving average of $10.80. The company’s market cap is $332.8 million.
GW Pharmaceuticals Plc – American Depositary Shares (NASDAQ:GWPH) last released its earnings data on Monday, August 5th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.13. The company had revenue of $11.04 million for the quarter, compared to the consensus estimate of $10.71 million.
GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the research, development and commercialization of a range of cannabinoid prescription medicines to meet patient needs in a range of medical conditions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.